In the paper by Raikes et al. (“Exploratory imaging outcomes of a phase 1b/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: Structural effects and functional connectivity outcomes.” Alzheimer's Dement. 2022;8:e12258. https://doi.org/10.1002/trc2.12258), errors occurred in the preparation of the paper for publication, requiring the following corrections.
In the second sentence of the first paragraph of section 3.1, the term ‘APIOE’ should have been spelled ‘APOE’.
In the Acknowledgments section, in the second sentence, the name of the university was incorrectly listed as “University of California” and should have been listed as “University of Southern California”.
In the Conflict of Interest section, in the last sentence, the author's name should have been spelled ‘Roberta D. Brinton’.
We regret the errors.